Sitamaquine tosylate structure
|
Common Name | Sitamaquine tosylate | ||
|---|---|---|---|---|
| CAS Number | 1019640-33-5 | Molecular Weight | 515.70800 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C28H41N3O4S | Melting Point | N/A | |
| MSDS | USA | Flash Point | N/A | |
Use of Sitamaquine tosylateSitamaquine (WR 6026) tosylate, an orally active 8-aminoquinoline analog, is an antileishmanial agent. Sitamaquine is a lipophilic weak base that rapidly accumulates in acidic compartments of Leishmania spp., mainly in acidocalcisomes[1]. |
| Name | N,N-Diethyl-N'-(6-methoxy-4-methyl-8-quinolinyl)-1,6-hexanediamin e 4-methylbenzenesulfonate (1:1) |
|---|---|
| Synonym | More Synonyms |
| Description | Sitamaquine (WR 6026) tosylate, an orally active 8-aminoquinoline analog, is an antileishmanial agent. Sitamaquine is a lipophilic weak base that rapidly accumulates in acidic compartments of Leishmania spp., mainly in acidocalcisomes[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C28H41N3O4S |
|---|---|
| Molecular Weight | 515.70800 |
| Exact Mass | 515.28200 |
| PSA | 100.14000 |
| LogP | 7.26140 |
| RIDADR | NONH for all modes of transport |
|---|
| Sitagliptin phosphate hydrate |
| (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine dihydrogenphosphate monohydrate |
| Sitagliptin phosphate hydrate (jan) |
| Sitagliptin monohydrate |
| sitamaquine tosylate |
| 3(R)-3-amino-1-[3-(trifluoromethyl)-5H,6H,7H,8H [1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one phosphate monohydrate |
| Sitagliptin phosphate (usan) |
| N,N-diethyl-N'-[4-methyl-6-(methyloxy)-8-quinolinyl]-1,6-hexanediamine tosylate |
| Januvia (tn) |
| Sitagliptin phosphate for research |
| 7-[(3R)-3-Amino-1-oxo-4-(2,4,5-trifluorophenyl)Butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazinephosphatemonohydrate |